Because of the potential clinical use of the currently available echinocandins: anidulafungin, caspofungin and micafungin, and to address questions regarding effects on the life cycle and transmission of Pneumocystis spp
es and activates p53 which then blocks cellular proliferation. Alternatively, ARF inhibits cellular growth...